Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001794571 | SCV002032382 | uncertain significance | not provided | 2021-04-23 | criteria provided, single submitter | clinical testing | Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Ambry Genetics | RCV002541269 | SCV003721384 | uncertain significance | Inborn genetic diseases | 2022-11-21 | criteria provided, single submitter | clinical testing | The c.9262C>T (p.P3088S) alteration is located in exon 59 (coding exon 59) of the DYNC2H1 gene. This alteration results from a C to T substitution at nucleotide position 9262, causing the proline (P) at amino acid position 3088 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Breakthrough Genomics, |
RCV001794571 | SCV005191490 | uncertain significance | not provided | criteria provided, single submitter | not provided |